Form 4 · Filed Jun 30, 2026, 08:52 PM UTC
NBIX/NEUROCRINE BIOSCIENCES INC
Lippoldt Darin — Chief Legal Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
9 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 29, 2026 | M | other | 1,690 | — | — | 14,965 |
| Jun 29, 2026 | M | other | 1,690 | $81 | $137,718 | 56,419 |
| Jun 29, 2026 | S | sell | 1,690 | $171 | $288,676 | 54,729 |
| Jun 29, 2026 | M | other | 8,110 | — | — | 16,655 |
| Jun 29, 2026 | M | other | 8,110 | $81 | $660,884 | 62,839 |
| Jun 29, 2026 | S | sell | 8,110 | $170 | $1,378,903 | 54,729 |
| Jun 26, 2026 | S | sell | 200 | $170 | $33,913 | 54,729 |
| Jun 26, 2026 | M | other | 200 | — | — | 24,765 |
| Jun 26, 2026 | M | other | 200 | $81 | $16,298 | 54,929 |
Source: SEC EDGAR raw filing ↗ · Accession 0001504783-26-000015